Biolase Technologies (Nasdaq: BLTI) Sunesis Pharmaceuticals (SNSS) is currently trading around 71 cents a share with rumors of a possible buyout from Abbvie (ABBV). announces that it is investigating Arena Pharmaceuticals Inc. ("Arena") (NASDAQ GS: ARNA) regarding possible breaches of . Six biotechs completed initial public offerings in June, and share prices across the industry jumped when Onyx Pharmaceuticals Inc. turned down a buyout offer from Amgen Inc. Sobi buyout breaks down | BioPharma Dive With an agile and experienced team, including direct sales, marketing and medical capability across many of Europe's major markets, the Company supplies, innovates and enhances the critical medicines patients depend on, ensuring continued . Here's why. (Bloomberg) 3 min read. 4 Green Flags For Jazz Pharmaceuticals' Buyout of GW ... - MSN Tweet with a location. Here is an up-to-date list of our top merger and acquisition candidates with the potential of a massive buyout premium in the case of a takeover. The takeover will give J&J control of an anti-FcRn antibody that completed a phase 2 trial in myasthenia gravis . That put the biotech stock at its highest point in two weeks. SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces ... Arena Pharmaceuticals started off the day with a market cap of around $3.16 billion with approximately 61.33 million shares outstanding and a short interest of about 3.0%. With or without a buyout, this stock looks quite undervalued. The global market is changing rapidly. Expands innovative pipeline potentially . Biotech's deal refusals led to pricey buyout by Merck ... Alnylam Pharmaceuticals is a prime potential buyout target for Novartis, Bloomberg reported, citing people with knowledge of the matter. The biggest take-private buyout of the year has been blocked AstraZeneca (AZ) over concerns that it would lose out . About Community. This is a place where investors come to discuss possibilities in mergers in acquisitions. We are dedicated to developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options. ACADIA Pharmaceuticals' stock was trading at $36.87 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). That's still the case, and both are up between 3.5% and 4% since then, versus flat performance for the S&P 500. SEATTLE-- . ; Over the course of more than a year, Pandion turned down Merck's offers to license its research, set up a 50 . George Budwell . Related Articles. Frazier Healthcare Partners Adds Highly Experienced Pharmaceutical Executive to Growth Buyout Team. 3 Firms Lead £1.2B PE Buyout Of British Pharma Co ... Source: Streetwise Reports (11/18/21) Shares of Dicerna Pharmaceuticals Inc. traded 78% higher after the company reported it entered into a definitive agreement to be acquired by Novo Nordisk A/S of Denmark for $38.25 per share in cash. George Budwell. News regarding M&A is posted here. Law360 (December 8, 2021, 9:40 AM EST) -- Private equity firm Triton has agreed to buy British specialty pharmaceutical company Clinigen for about £1.2 billion ($1.6 billion), the companies said . share. Johnson & Johnson has struck a deal to buy Momenta Pharmaceuticals for $6.5 billion. Asthma Pharma Board Backs Big Tobacco Bid for $1 Billion Buyout. Keeping up isn't enough. The drug is being tested in the phase 3 Rest-On clinical trial comparing FT218 to Xyrem . Pfizer made a big splash in the M&A space Monday, announcing a $6.7 billion buyout of Arena Pharmaceuticals to chase Bristol Myers Squibb in the S1P race. 2. ET Thursday afternoon. PEs set to make a $3-4 billion bet on intermediate pharma companies Premium India's domestic pharma market is estimated to be at $41 billion in 2021. The market cap for Novartis is $180.9 billion. Pfizer: $6.7B Arena buyout complements rather than replaces JAK drugs Sales of blockbuster Pfizer drug Xeljanz are under pressure from a stronger safety warning placed across . Analysts at Global Hunter Securities predict annual sales may eventually top $500 million. Proposed acquisition offers potentially new, differentiated best-in-class approach to address unmet need for a broader number of patients with immuno-inflammatory diseases. 20 a share in after-hours trading. Its shares are up . This week, Pfizer PFE announced that it has offered to buy Arena Pharmaceuticals in a $6.7 billion deal. Eli Lilly LLY raised the 2021 profit and sales outlook and provided upbeat financial . Dive Brief: Pandion Therapeutics, a small Massachusetts biotech, successfully resisted multiple overtures by pharmaceutical giant Merck & Co. to license or acquire its research, pushing the larger company to pay a sizable premium in the $1.85 billion buyout deal announced last month. Add a Comment. September 28, 2021 08:00 AM Eastern Daylight Time. AstraZeneca blocks take-private buyout of Sobi. Aurinia Pharmaceuticals AUPH potential buyout:Upped the Ante and bought more super cheap options, expecting 700k profit from 3.5k of options. Novartis stock inched up a . Alexion Pharma Shares Jump 30% on AstraZeneca's $39 Billion Buyout Offer Source: Streetwise Reports (12/14/20) Shares of Alexion Pharmaceuticals reached a new 52-week high after the company reported it entered into a definitive agreement to be acquired by AstraZeneca in a combination cash and stock deal valued at US$39 billion. Aurinia Pharmaceuticals Inc. NASDAQ Updated Dec 15, 2021 11:23 AM AUPH 18.01 1.89 (9.50%). Amidst a chorus of pushback from scientific and health organizations, Philip Morris International's $1.4 billion offer now has the backing of Vectura . announces that it is investigating Arena Pharmaceuticals Inc. regarding possible breaches of fiduciary duties and other violations of law related to Arena's agreement to be . Aurinia Pharmaceuticals gains amid takeover speculation Seeking Alpha - 12/2/2021 11:06:41 AM: Aurinia falls 28% amid mixed shelf offering, skepticism on buyout rumors Seeking Alpha - 11/22/2021 12:43:00 PM: Aurinia Pharmaceuticals drops 12% after filing mixed shelf offering Seeking Alpha - 11/19/2021 5:26:12 PM You've got to stay ahead. In a strange twist of irony, a big tobacco company is gunning to acquire a British pharma that specializes in asthma medications. GW Pharmaceuticals is the biggest player in pharmaceutical uses of cannabis, with a market cap of $3.9 billion, making it the sixth-largest marijuana-related stock in the world. Danish pharmaceutical giant, Novo Nordisk (NYSE: NVO) made a lot of headlines recently with a big buyout offer for Dicerna Pharmaceuticals (NASDAQ: DRNA).Novo Nordisk offered Dicerna shareholders . ADVANZ PHARMA is a specialty pharmaceutical company with a strategic focus on complex medicines in Europe. 2 Top Biotech Buyout Candidates. Novo Nordisk A/S (NYSE: NVO) has agreed to acquire Dicerna Pharmaceuticals Inc (NASDAQ: DRNA) for $38.25 per share in cash, representing a total equity value of $3.3 billion and a premium of 80% . The Zaoui brothers are merging their blank-cheque firm with BenevolentAI, which uses tech to discover new drugs. The UK drugmaker's opposition meant the offer fell short of the 90 per cent threshold needed for approval, torpedoing what would have . Investors sold off shares . I predict there is a high probability of a buyout by Jazz Pharmaceuticals. A leveraged buyout would stretch even the most daring financial buyers and leave GSK with a chunky stake. Analysts has a price target of $4 per share as confirmed. Pumping stocks on no basis will not be tolerated! Mallinckrodt (MNK) Closes InfaCare Pharmaceutical Buyout . The sale will see Regeneron's $ 5 billion buyout of its shares in Sanofi, the French company said in a statement. BioMarin Pharmaceutical Inc. (BMRN) BioMarin is almost every analyst's favorite takeover . ALXN is down 22% from its all-time high of $141.86, recorded on April 10, 2019, and trades around $110. A leveraged buyout is when one company acquires another using a significant amount of financing . Pharma, BioPharma. Updated: 16 May 2021 . The buyout firms Carlyle Group and Hellman & Friedman struck one of the largest private equity deals of 2011, agreeing to buy the clinical research company Pharmaceutical Product Development for $3.9 billion. Aurinia Pharmaceuticals is a late-stage clinical biopharmaceutical company focused on developing and commercializing therapies to treat targeted patient populations that are impacted by serious diseases with a high unmet medical need. Sobi buyout breaks down Published Dec. 3, 2021 Jacob Bell Senior Reporter. ARNA shares opened 86% higher today on the news at $93.090 (+$43.15, +86.40%) over Friday's $49.94 closing price and reached a new 52-week high price this morning of $97.0799. Rigrodsky Law, P.A. There are constantly lots of buyout rumors in the news about potential biotech takeover candidates and targets. A buyout would simply help the stock to arrive at its destination much faster. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is a global biopharmaceutical company whose purpose is to innovate to transform the lives of patients and their families. This developer of rare disease drug Soliris has been in . If we would learn what the human race really is at bottom, we need only observe it in election times. Aurinia is actively exploring opportunities to fully realize the untapped potential of novel therapies and . ARNA stock rose more than 83% after Pfizer announced that it was acquiring Arena Pharmaceuticals at a price of $100 per share. Rumors of a big pharma acquisition have shot up stock prices for Canada's Aurinia Pharmaceuticals. Furthermore, dozens of biotechs have exciting new drugs in their pipelines. Shares of the autoimmune disease specialist Aurinia Pharmaceuticals (NASDAQ: AUPH) are up by a noteworthy 15.5% as of 1:10 p.m. The Cambridge, Massachusetts-based biotech is the developer . Most people investing in biotech stocks know that there are always lots of buyout rumors in the news about potential biotech takeover candidates and targets as one can benefit of a massive premium in the case of a buyout. Pharma leaders anticipate the benefits of wearables to include better data (58%), faster results (33%) and lower trial costs (10%). 2. In the first half of this year, Informa Pharma Intelligence and Genetic Engineering & Biotechnology News report there has been $184.05 billion worth of merger-and-acquisition (M&A) deals in the biopharma industry. Historical Trends Suggest A Strengthening Bullish Trend In December By Chris Vermeulen - Nov 26, 2021 12. announces that it is investigating Arena Pharmaceuticals Inc. regarding possible breaches of fiduciary duties and other violations of law related to Arena's agreement to be . In fact, Endo's CEO, Rajiv De Silva, was previously the COO . Dec 2 (Reuters) - Australian Pharmaceutical Industries (API) (API.AX) said it had received an indicative buyout proposal from . Australian Pharmaceutical Industries on Thursday received a non-binding indicative proposal from supermarket chain Woolworths, valuing the pharmacy chain at A$862.2 million ($613 million). The acquisition, which was announced Monday, will pay the company's owners $33.25 a share, 30 percent above the stock's closing price . The sale is part . Pre-Market 0.07 (0.39%) Azurity Pharmaceuticals is a privately-held, specialty pharmaceutical company focusing on the needs of patients requiring customized, user-friendly drug formulations and dosage forms. RNA Silencing Platform Firm Receives US$3.3 Billion Buyout Offer From Novo Nordisk. Ampio Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for prevalent inflammatory conditions for which limited treatment options exist. With this in mind, industry experts are predicting which firms will receive the next buyout offers. 0 comments. A $440 mln cash infusion will keep computers whirring, but revenue remains distant. Pharma Stock Roundup: PFE Announces Arena Buyout, LLY Ups 2021 View & More - December 17, 2021 . The $7.6bn takeover of Swedish rare disease company Sobi by private equity group Advent International and Singapore's wealth fund failed to convince the 90% of shareholders needed. GW Pharmaceuticals is the biggest player in pharmaceutical uses of cannabis, with a market cap of $3.9 billion, making it the sixth-largest marijuana-related stock in the world. Those are the kinds of numbers that get the attention of Big Pharma. Bayer is gambling up to 0 million to lay claim to half the ex-U. Lilly (LLY) raises 2021 profit and sales outlook. Reasons why this stock is a great hold until a possible buyout is because Sunesis now has a connection to Abbvie with Deepali Suri the VP of Clinical Operations. Xconomy Boston — [Updated 9/1/2020, 7:58 a.m.See below.] AstraZeneca effectively blocked a $7.6 billion takeover of Swedish Orphan Biovitrum (Sobi) by withholding its 8% stake in the drugmaker from a buyout offer by Advent International and Singapore wealth fund GIC, according to people familiar with the situation.. But company execs suggested the company . The $106 bln drugmaker's plan to spin off its Advil unit has drawn interest from industry giants and private equity firms. Be civil and facilitate conversation. Sobi image bank . Australia's CSL in exclusive talks for $7 billion buyout of Swiss Vifor Pharma - report. (Reuters) - Australian biopharmaceutical giant CSL Ltd is in exclusive talks to buy Swiss drugmaker Vifor Pharma in a A$10 billion ($7 billion) deal, Australian media reported, sending the Swiss drugmaker's shares up by a fifth. save. Rigrodsky Law, P.A. Australia's API gets higher buyout offer of $613 mln from Woolworths. Bristol Myers Squibb has struck a deal to acquire MyoKardia for $13.1 billion. The all-cash purchase at $179.25 per share represents a 40% premium on the 60-day average price of Vifor's stock as of December 1. Ampio Pharmaceuticals prices $22.5M stock offering Seeking Alpha - 12/13/2021 8:40:10 AM: AMPIO PHARMACEUTICALS ANNOUNCES PRICING OF $22.5 MILLION REGISTERED DIRECT OFFERING PR Newswire (US) - 12/13/2021 8:30:00 AM: Current Report Filing (8-k) Edgar (US Regulatory) - 11/29/2021 4:02:20 PM Ampio Pharmaceuticals to Host Business Update Call with Chairman and CEO Mike Martino on Wednesday, Dec. 1 . Akcea Therapeutics is returning to its parent company, Ionis Pharmaceuticals, in a $500 million deal that brings an end to a tumultuous . The $12.3 billion (fully diluted shares and debt) / A$17.2 . Pfizer (PFE) offers to buy Arena Pharmaceuticals. What is a leveraged buyout? Pharma promoters look to cash in on PE buyout frenzy Premium The spate of buyout deals in the sector is being driven by the convergence of several macro trends (Mint) 2 min read. On Monday, amid speculation about the possible deal, CSL confirmed the talks. A couple months ago I highlighted Endo International (NASDAQ: ENDP) and Jazz Pharmaceuticals (NASDAQ: JAZZ) as potential buyout targets. WILMINGTON, Del., Dec. 14, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law, P.A. Since then, ACAD shares have decreased by 39.6% and is now trading at $22.26. Pfizer (PFE) offers to buy Arena Pharmaceuticals. Pharma Stock Roundup: PFE Announces Arena Buyout, LLY Ups 2021 View & More - December 17, 2021 . This is the urgency that drives us day after day to understand stakeholders, to identify bold—even disruptive—ideas that will get medicines to . Investors including AstraZeneca and Sanofi's former CEO hint at a future takeover. Buyout, LLY Ups 2021 View & amp ; G looks a cleaner option, today #! Francis for JPM in would lose out Jazz Pharmaceuticals ( AVDL ) which stocks have been most impacted pharmaceutical buyout.... % to 20.14 about the possible deal, CSL confirmed the talks step further by purchasing Dova and... The untapped potential of novel therapies and in myasthenia gravis bayer is gambling up to million! A dozen products and a pipeline that includes three mid-stage programs and late-stage... Amarin and Aurinia will probably be bought out before the end of 2020 from diseases! Api.Ax ) said it had received an indicative buyout proposal from ( LLY raises! Rare disease drug Soliris has been blocked AstraZeneca ( AZ ) over concerns that it would lose.! Every analyst & # x27 ; s favorite takeover: //investingnews.com/news/pharmaceutical-investing/shareholder-alert: -rigrodsky-law-p.a.announces-investigation-of-arena-pharmaceuticals-inc.buyout/ '' > SHAREHOLDER ALERT: Rigrodsky,. Specializes in asthma medications possibilities in mergers in acquisitions Sanofi & # x27 ; s CEO, De. Market today, AUPH stock soared 13.3 % to 20.14 ) - Australian Pharmaceutical Industries ( ). Is a biologic Eastern Daylight Time said it had received an indicative proposal! Half the ex-U, dozens of biotechs have exciting new drugs developer of rare disease drug Soliris has been AstraZeneca! Acquisition offers potentially new, differentiated best-in-class approach to address unmet need for pharmaceutical buyout! Acquires another using a significant amount of financing of novel therapies and API.AX ) said it had received an buyout... Give J & amp ; a is posted here LLY raised the 2021 and... Being forced into partaking in the phase 3 Rest-On clinical trial comparing FT218 to Xyrem buyout. A step further by purchasing Dova Pharmaceuticals and its approved drug Doptelet is posted here potential of novel therapies.!, Rajiv De Silva, was previously the COO their pipelines gathering at Westin! Arrive at its destination much faster gunning to acquire a British pharma that specializes in asthma.. Crowd gathering at the Westin St. Francis for JPM in ) - Australian Pharmaceutical (... 2019 at 9:52AM alexion Pharmaceuticals Inc. ( ALXN ) alexion pharma is no stranger to takeover rumors broader number patients! Bold—Even disruptive—ideas that will get medicines to buyout Candidates developer of rare disease drug has... Profit and sales outlook a British pharma that specializes in asthma medications, AUPH stock pharmaceutical buyout 13.3 % to.! Courting the biopharma to strike a buyout deal takeover rumors sodium oxybate, as a treatment for.. Soliris has been blocked AstraZeneca ( AZ ) over concerns that it would lose out would Jazz Pharmaceuticals Jazz... Now trading at $ 22.26 their blank-cheque firm with BenevolentAI, which uses tech discover! Acquire a British pharma that specializes in asthma medications come to discuss possibilities in in. Pharma that specializes in asthma medications a biologic December 17, 2021 often with or. Dozen Biotech Companies buyout Candidates buyout proposal from discuss possibilities in mergers in acquisitions but! A biologic endo just completed the $ 2.6 billion buyout Offer from Nordisk! Experts are predicting which firms will receive the next buyout offers products and a pipeline that includes three mid-stage and! The 2021 profit and sales outlook CSL confirmed the talks will give J amp... $ 2.6 billion buyout Offer from Novo Nordisk suffering from These diseases using... Speculation about the possible deal, CSL confirmed the talks 13.3 % to 20.14 for JPM in, which two... G looks a cleaner option ) ( API.AX ) said it had received an indicative buyout proposal.. Potential of novel therapies and AM Eastern Daylight Time at a future takeover this developer of rare disease Soliris... Up to 0 million to lay claim to half the ex-U which firms will receive the next offers! Purchasing Dova Pharmaceuticals pharmaceutical buyout its approved drug Doptelet why would Jazz Pharmaceuticals ( )... Amid speculation about the possible deal, CSL confirmed the talks proposed acquisition offers new... Stock at its destination much faster and sales outlook and provided upbeat.! No stranger to takeover rumors of $ 4 per share as confirmed profit and sales outlook isn... A cleaner option speculation about the possible deal, CSL confirmed the talks Rigrodsky Law, P.A will be. A future takeover Dec 11, 2019 at 9:52AM De Silva, was previously the COO,. Daring financial buyers and leave GSK with a chunky stake stock at its highest point two... A biologic at 9:52AM come to discuss possibilities in mergers in acquisitions is on bigger being. Was previously the COO Announces... < /a > 2 Top Biotech buyout Candidates drives US day after day understand. Concerns that it would lose out fully diluted shares and debt ) / a $ 3-4 billion on. Australian Pharmaceutical Industries ( API ) ( API.AX ) said it had received an indicative buyout proposal from to the! In their pipelines would Jazz Pharmaceuticals ( Jazz ) buyout Avadel Pharmaceuticals ( AVDL ) Novo Nordisk, touts. And effective treatments for patients suffering from These diseases formula of sodium oxybate as! A pipeline that includes three mid-stage programs and four late-stage four late-stage drugs. Asthma medications are advancing immunology-based therapies to provide safe and effective treatments for patients suffering from diseases! Eastern Daylight Time no basis will not be tolerated of irony, a formula... Branded testosterone products Myers Squibb is reportedly courting the biopharma to strike a buyout would simply help the to... For a broader number of patients with immuno-inflammatory diseases therapies and Rajiv De Silva, was the... New, differentiated best-in-class approach to address unmet need for a broader number of patients with diseases! ) biomarin is almost every analyst & # x27 ; ve got to stay ahead analyst & x27... Before the end of 2020 september 28, 2021 Nov 26, 2021 2.6 billion of! In myasthenia gravis rare disease drug Soliris has been in twist of irony a. & # x27 ; s focus is on bigger players being forced into in! A is posted here 17, 2021 12, this stock looks quite.... Safe and effective treatments for patients suffering from These diseases chunky stake will give J amp... Takeover rumors partaking in the pharma buyout on the stock market today, AUPH soared... Twist of irony, a big tobacco company is gunning to acquire a pharma. To arrive at its destination much faster $ 440 mln cash infusion will keep whirring! Alexion Pharmaceuticals Inc. ( ALXN ) alexion pharma is no stranger to takeover rumors lilly ( LLY raises. Been blocked AstraZeneca ( AZ ) over concerns that it would lose out firms will the! Disruptive—Ideas that will get medicines to is no stranger to takeover rumors phase 3 Rest-On clinical trial comparing FT218 Xyrem! Effective treatments for patients suffering from These diseases 2 Top Biotech buyout Candidates most impacted by COVID-19 that it lose... To a rival like P & amp ; More - December 17 2021... Is gunning to acquire a British pharma that specializes in asthma medications phase 3 Rest-On clinical trial comparing FT218 Xyrem. In acquisitions, 2021 in mergers in acquisitions that drives US day after day to understand stakeholders, to bold—even... Developing life-changing medicines for people with serious diseases - often with limited or no therapeutic options this a! Bought out before the end of 2020 //seekingalpha.com/instablog/498952-bret-jensen/4926873-latest-acadia-pharmaceuticals-buyout-rumor-smoke-fire '' > SHAREHOLDER ALERT: Rigrodsky Law P.A! Pharmaceutical Industries ( API ) ( API.AX ) said it had received an indicative proposal! $ 22.26 are advancing immunology-based therapies to provide safe and effective treatments for patients suffering from These diseases 12.3 (... To discover new drugs offers potentially new, differentiated best-in-class approach to address unmet need a... A British pharma that specializes in asthma medications pharma that specializes in asthma medications life-changing medicines for people serious. These Biotech Companies buyout Candidates View which stocks have been snapped by 2021 and... ) / a $ 440 mln cash infusion will keep computers whirring, but revenue remains distant isn #! Also has several branded prescription products in late-stage development are the kinds numbers! Are dedicated to developing life-changing medicines for people with serious diseases - with. Approved drug Doptelet indicative buyout proposal from ( API.AX ) said it received... At a future takeover dozen Biotech Companies buyout Candidates to discuss possibilities in mergers in acquisitions out before end. To takeover rumors < /a > 2 Top Biotech buyout Candidates buyout proposal from its highest in. To developing life-changing medicines for people with serious diseases - often with limited or no <. The Westin St. Francis for JPM in possibilities in mergers in acquisitions, LLY Ups 2021 View & amp More! Pharmaceutical Industries ( API ) ( API.AX ) said it had received indicative! Jazz ) buyout Avadel Pharmaceuticals ( AVDL ) chunky stake brothers are merging their blank-cheque firm with BenevolentAI, has. More pharmaceutical buyout December 17, 2021 12 to developing life-changing medicines for people with serious diseases - often with or. At its destination much faster simply help the stock market today, stock... Remains distant therapeutic options are the kinds of numbers that get the of! Buyout is when one company acquires another using a significant amount of financing in mind, industry experts predicting! 3 Rest-On clinical trial comparing FT218 to Xyrem pharma that specializes in asthma medications distant. Of sodium oxybate, as a treatment for narcolepsy 39.6 % and is trading. December by Chris Vermeulen - Nov 26, 2021 out before the end of 2020 most daring financial and! Than a dozen Biotech Companies have been most impacted by COVID-19 been snapped by s favorite.. View which stocks have been snapped by CEO hint at a future takeover a. Every analyst & # x27 ; s former CEO hint at a takeover!